Lecture No 11 (Non Narcotics Analgetics)
Lecture No 11 (Non Narcotics Analgetics)
SALICYLATES
Aspirin (acetylsalicylic acid)
It is one of the oldest analgesic-antiinflammatory drugs and is still widely
used.
PHARMACOLOGICAL ACTIONS
1. Analgesic, antipyretic, antiinflammatory actions. Aspirin is a weaker
analgesic than morphine type drugs.
2. Metabolic effects. There is increased utilization of glucose blood sugar may
decrease (specially in diabetics). Chronic use of large doses cause negative N 2
balance. Plasma free fatty acid and cholesterol levels are reduced.
3. Respiration is stimulated by peripheral (increased CO 2 production) and central
(increased sensitivity of respiratory centre to CO2) actions. Further rise in salicylate
level causes respiratory depression; death is due to respiratory failure.
4
4. Acid-base and electrolyte balance. It causes respiratory alkalosis, which is
compensated by increased renal excretion of HCO3. Aspirin is acid, it causes
metabolic acidosis.
5. GIT Aspirin and released salicylic acid irritate gastric mucosa cause
epigastric distress, nausea and vomiting. Aspirin causes focal necrosis of mucosal
cells and capillaries acute ulcers, erosive gastritis, congestion and microscopic
haemorrhages. Soluble aspirin tablets containing calcium carbonate + citric acid
and other buffered preparations are less liable to cause gastric ulceration.
6. Urate excretion. In higher dose aspirin increases urate excretion.
7. Blood Aspirin, even in small doses, irreversibly inhibits TXA2 synthesis by
platelets and decreases aggregation. Long term intake of large dose decreases syn-
thesis of clotting factors and predisposes to bleeding; can be prevented by
prophylactic vit K therapy.
ADVERSE EFFECTS
(a) Side effects. that occur at analgesic dose (0.3-1.5 g/day) are nausea, vomiting,
epigastric distress, increased occult blood loss in stools. The most important
adverse effect of aspirin is gastric mucosal damage and peptic ulceration.
(b) Hypersensitivity and idiosyncrasy. Reactions include rashes, fixed drug
eruption, urticaria, rhinorrhoea, angioedema, asthma and anaphylactoid reaction.
Profuse gastric bleeding occurs in rare instances.
(c) Antiinflammatory doses (3-6 g/day) produce the syndrome called salicylism—
dizziness, tinnitus, vertigo, reversible impairment of hearing and vision,
excitement and mental confusion, hyperventilation and electrolyte imbalance.
(d) An association between salicylate therapy and 'Reye's syndrome', a rare form of
hepatic encephalopathy seen in children having viral (varicella, influenza)
infection has been noted.
USES
1. As analgesic. For headache, backache, myalgia, joint pain, pulled muscle,
toothache, neuralgias and dysmenorrhoea.
2. As antipyretic.
5
3. Acute rheumatic fever, rheumatoid arthritis, osteoarthritis.
4. Postmyocardial infarction and poststroke patients. By inhibiting platelet
aggregation it lowers the incidence of reinfarction (60-100 mg/day).
PYRAZOLONES
Metamizol (Dipyrone) It is a potent and promptly acting analgesic and
antipyretic but poor antiinflammatory and not uricosuric. It can be given orally,
i.m. as well as i.v. but gastric irritation, pain at injection site occurs. Occasionally
i.v. injection produces precipitous fall in BP.
Metamizol was banned in USA and some European countries, because it causes
bone marrow depression, agranulocytosis, epigastric distress and edema. However,
it has been extensively used in India and other European countries.
INDOLE DERIVATIVES
1. Indomethacin It is a potent antiinflammatory drug, comparable to
phenylbutazone. In addition, it is a potent and promptly acting antipyretic.
Analgesic action is better than phenylbutazone, but it relieves only inflammatory
or tissue injury related pain. It is a highly potent inhibitor of PG synthesis and
suppresses neutrophil motility..
Adverse effects. A high incidence (upto 50%) of gastrointestinal and CNS side
effects is produced. Gastric irritation, nausea, anorexia, gastric bleeding and
diarrhoea are prominent. Headache, dizziness, ataxia, mental confusion,
hallucination, depression and psychosis. Leukopenia, rashes and other
hypersensitivity reactions are also reported.
Uses. In rheumatoid arthritis, ankylosing spondylitis, acute exacerbations of
destructive arthropathies and psoriatic arthritis.
It has been the most common drug used for medical closure of patent ductus
arteriosus: three 12 hourly doses of 0.1-0.2 mg/kg.
PYRROLO-PYRROLE DERIVATIVE
Ketorolac. A novel NSAID with potent analgesic and modest
antiinflammatory activity. In postoperative pain it has equalled the efficacy of
morphine, but does not interact with opioid receptors and is free of respiratory
depressant, dependence producing.
Ketorolac is rapidly absorbed after oral and i.m. administration.
Ketorolac has been used concurrently with morphine. However, it should not
be given to patients on anticoagulants.
Use. Ketorolac is frequently used in postoperative and acute musculoskeletal
pain. It may also be used for renal colic, migraine and pain due to bony metastasis.
Continuous use for more than 5 days is not recommended.